A dual drug regimen synergistically blocks human parainfluenza virus infection

Human parainfluenza type-3 virus (hPIV-3) is one of the principal aetiological agents of acute respiratory illness in infants worldwide and also shows high disease severity in the elderly and immunocompromised, but neither therapies nor vaccines are available to treat or prevent infection, respectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Bailly, Benjamin, Dirr, Larissa, El-Deeb, Ibrahim M., Altmeyer, Ralf, Guillon, Patrice, von Itzstein, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823791/
https://www.ncbi.nlm.nih.gov/pubmed/27053240
http://dx.doi.org/10.1038/srep24138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823791/
https://www.ncbi.nlm.nih.gov/pubmed/27053240
http://dx.doi.org/10.1038/srep24138

Ejemplares similares